Author
Listed:
- Ilaria Castiglioni
(IRCCS San Raffaele Scientific Institute)
- Roberta Caccia
(IRCCS San Raffaele Scientific Institute)
- Jose Manuel Garcia-Manteiga
(IRCCS San Raffaele Scientific Institute)
- Giulia Ferri
(IRCCS San Raffaele Scientific Institute)
- Giuseppina Caretti
(University of Milan)
- Ivan Molineris
(IRCCS San Raffaele Scientific Institute)
- Kenichi Nishioka
(Saga University
RIKEN IMS)
- Davide Gabellini
(IRCCS San Raffaele Scientific Institute)
Abstract
Myoblast fusion (MF) is required for muscle growth and repair, and its alteration contributes to muscle diseases. The mechanisms governing this process are incompletely understood, and no epigenetic regulator has been previously described. Ash1L is an epigenetic activator belonging to the Trithorax group of proteins and is involved in FSHD muscular dystrophy, autism and cancer. Its physiological role in skeletal muscle is unknown. Here we report that Ash1L expression is positively correlated with MF and reduced in Duchenne muscular dystrophy. In vivo, ex vivo and in vitro experiments support a selective and evolutionary conserved requirement for Ash1L in MF. RNA- and ChIP-sequencing indicate that Ash1L is required to counteract Polycomb repressive activity to allow activation of selected myogenesis genes, in particular the key MF gene Cdon. Our results promote Ash1L as an important epigenetic regulator of MF and suggest that its activity could be targeted to improve cell therapy for muscle diseases.
Suggested Citation
Ilaria Castiglioni & Roberta Caccia & Jose Manuel Garcia-Manteiga & Giulia Ferri & Giuseppina Caretti & Ivan Molineris & Kenichi Nishioka & Davide Gabellini, 2018.
"The Trithorax protein Ash1L promotes myoblast fusion by activating Cdon expression,"
Nature Communications, Nature, vol. 9(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-07313-8
DOI: 10.1038/s41467-018-07313-8
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-07313-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.